Evidence map›Paper›PMID 19321599›Full record

ArticleHuman molecular genetics2009

Loss-of-function mutations in ATP6V0A2 impair vesicular trafficking, tropoelastin secretion and cell survival.

Vishwanathan Hucthagowder, Eva Morava, Uwe Kornak, Dirk J Lefeber, Björn Fischer, Aikaterini Dimopoulou, Annika Aldinger, Jiwon Choi, Elaine C Davis, Dianne N Abuelo and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 139 citations in OpenAlex.

  1. Article
  2. Abnormal von Willebrand factor multimer pattern withoutBlood vessels, thrombosis & hemostasis · 2026
    Article
  3. Article
  4. Review
  5. Strabismus in Genetic Syndromes: A Review.Clinical & experimental ophthalmology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Role of elastic fiber degradation in disease pathogenesis.Biochimica et biophysica acta. Molecular basis of disease · 2023
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. The Golgi as a "Proton Sink" in Cancer.Frontiers in cell and developmental biology · 2021
    Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 16 institutions in 11 countries.

Vishwanathan HucthagowderDepartment of Pediatrics, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8208, St Louis, MO 63110, USA.
Eva Morava
Uwe Kornak
Dirk J Lefeber
Björn Fischer
Aikaterini Dimopoulou
Annika Aldinger
Jiwon Choi
Elaine C Davis
Dianne N Abuelo
Maciej Adamowicz
Jumana Al-Aama
Lina Basel-Vanagaite
Bridget Fernandez
Marie T Greally
Gabriele Gillessen-Kaesbach
Hulya Kayserili
Emmanuelle Lemyre
Mustafa Tekin
Seval Türkmen
Beyhan Tuysuz
Berrin Yüksel-Konuk
Stefan Mundlos
Lionel Van Maldergem
Ron A Wevers
Zsolt Urban
Charité - Universitätsmedizin Berlin · DEAnkara University · TRIstanbul University · TRMax Planck Institute for Molecular Genetics · DEMcGill University · CARadboud University Nijmegen · NLWashington University in St. Louis · USBrown University · USCentre Hospitalier Universitaire Sainte-Justine · CAChildren's Health Ireland at Crumlin · IEChildren's Memorial Health Institute · PLEastern Health · AUKing Abdulaziz University · SARafael Advanced Defense Systems (Israel) · ILUniversity of Liège · BEUniversity of Lübeck · DE

Funding

Registry And Data AnalysisP50HL084922 · NHLBI · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2007 to 2011
$14.0M
NHLBI NIH HHS HL084922NHLBI NIH HHS P50 HL084922
6 · The paper itself

Abstract

Autosomal recessive cutis laxa type 2 (ARCL2), a syndrome of growth and developmental delay and redundant, inelastic skin, is caused by mutations in the a2 subunit of the vesicular ATPase H+-pump (ATP6V0A2). The goal of this study was to define the disease mechanisms that lead to connective tissue lesions in ARCL2. In a new cohort of 17 patients, DNA sequencing of ATP6V0A2 detected either homozygous or compound heterozygous mutations. Considerable allelic and phenotypic heterogeneity was observed, with a missense mutation of a moderately conserved residue p.P87L leading to unusually mild disease. Abnormal N- and/or mucin type O-glycosylation was observed in all patients tested. Premature stop codon mutations led to decreased ATP6V0A2 mRNA levels by destabilizing the mutant mRNA via the nonsense-mediated decay pathway. Loss of ATP6V0A2 either by siRNA knockdown or in ARCL2 cells resulted in distended Golgi cisternae, accumulation of abnormal lysosomes and multivesicular bodies. Immunostaining of ARCL2 cells showed the accumulation of tropoelastin (TE) in the Golgi and in large, abnormal intracellular and extracellular aggregates. Pulse-chase studies confirmed impaired secretion and increased intracellular retention of TE, and insoluble elastin assays showed significantly reduced extracellular deposition of mature elastin. Fibrillin-1 microfibril assembly and secreted lysyl oxidase activity were normal in ARCL2 cells. TUNEL staining demonstrated increased rates of apoptosis in ARCL2 cell cultures. We conclude that loss-of-function mutations in ATP6V0A2 lead to TE aggregation in the Golgi, impaired clearance of TE aggregates and increased apoptosis of elastogenic cells.

Indexed as

MutationAmino Acid SequenceApoptosisCells, CulturedCell SurvivalChild, PreschoolCohort StudiesCutis LaxaCytoplasmic VesiclesFemaleFibroblastsGolgi ApparatusHumansInfantMaleMolecular Sequence DataATP6V0A2 protein, humanProton-Translocating ATPasesTropoelastin

Identifiers

PMID19321599
PMCPMC2685755
OpenAlexW2104243245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.